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TO THE EDITOR
Eczema is caused by complex gene–
environmental interactions. The gene
encoding filaggrin (FLG) on chromo-
some 1q21 reported initially by
genome-wide linkage scan has been
the most consistently replicated one in
Caucasian children (Palmer et al.,
2006; Brown and McLean, 2009). Such
finding was confirmed in a recent meta-
analysis (van den Oord and Sheikh,
2009). Nevertheless, all five known
FLG mutations were rare in our south-
ern Chinese children (Ching et al.,
2009), whereas ethnic-specific FLG
mutations were found in the Japanese
(Nomura et al., 2008), Singaporean
Chinese (Chen et al., 2011), and
Taiwanese (Hsu et al., 2009). A recent
study reported 10 FLG mutations,
which to our knowledge were previously
Table 1. Multi-locus interaction models by GMDR for plasma total IgE
concentration and circulating eosinophil percentage
Combination of SNPs CVC Test accuracy P1
Plasma total IgE concentration
rs2155219 9 0.565 0.0002
rs1933064_rs2155219 10 0.577 o0.0001
rs1933064_rs2155219_rs1892951 6 0.597 o0.0001
rs1933064_rs3862807_rs10793175_rs17135034 2 0.573 0.0016
Circulating eosinophil percentage
rs2155219 10 0.571 0.0006
rs2155219_rs7927894 8 0.575 0.0004
rs1933064_rs2155219_rs17135034 3 0.581 o0.0001
rs11584427_rs2155219_rs7927894_rs10751256 8 0.592 0.0002
Abbreviations: CVC, cross-validation consistency; GMDR, generalized multifactor dimensionality
reduction; SNP, single-nucleotide polymorphism.
1Based on 5,000 permutations.
Abbreviations: eos%, circulating eosinophil percentage; FLG, filaggrin; GMDR, generalized multifactor
dimensionality reduction; GWAS, genome-wide association study; logIgE, logarithm-transformed plasma
total IgE concentration; MAF, minor allele frequency; SNP, single-nucleotide polymorphism
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unreported, for eczema in Han Chinese
(Zhang et al., 2011). We postulated
that eczema is also related to its single-
nucleotide polymorphisms (SNPs).
The first genome-wide association study
(GWAS) for eczema found a common
noncoding variant, rs7927894, on chro-
mosome 11q13 to have the strongest
association with eczema in German
children (Esparza-Gordillo et al., 2009).
Such association was replicated in the
Irish population (O’Regan et al., 2010).
Nevertheless, there are no data on the
interaction between FLG and 11q13
locus for eczema susceptibility.
In this case–control study, Chinese
children aged p18 years with physi-
cian-diagnosed eczema and non-
allergic controls were recruited to
investigate the relationship between
childhood eczema phenotypes and
tagging SNPs of FLG and 11q13. Their
total plasma and allergen-specific IgE
concentrations and circulating eosino-
phil percentage (eos%) were also
measured (see Supplementary Materials
online). Total IgE was log-transformed
(logIgE) before analysis. Subjects and
their parents gave informed written
consent. This study was approved by
our clinical research ethics committee
and performed according to the
Declaration of Helsinki Principles.
Genotypic data of SNPs spanning
20-kb flanking region of rs7927894 on
11q13 and 10 kb upstream and down-
stream of FLG on 1q21 were retrieved
from HapMap (McVean et al., 2005).
The details of tagging SNP selec-
tion and genotyping were described
in Supplementary Materials online,
and the linkage disequilibrium patterns
of SNPs in various ethnic groups are
provided in Supplementary Figures
S1–S5 online. Rs11584427 was in com-
plete linkage disequilibrium (r2¼1)
with two SNPs reported in an eczema
GWAS in Han Chinese (Sun et al.,
2011). The associations between SNP
and childhood eczema phenotypes were
analyzed by logistic or linear regression
using SPSS v.17 (SPSS, Chicago, IL),
with level of significance being 0.003
(0.05/17) to correct for multiple statistical
comparisons. The interactions among
SNPs for eczema phenotypes were
analyzed by generalized multifactor
dimensionality reduction (GMDR; see
Supplementary Materials online), and
significant findings were confirmed by
generalized linear model for normally
distributed logIgE or linear regression
for eos%, which did not follow normal
data distribution. One-way ANOVA and
Kruskal–Wallis test with post-hoc tests
were used to compare logIgE and eos%
among GMDR-defined risk groups.
A total of 1,230 Chinese eczema
patients and 1,113 controls were re-
cruited. Supplementary Table S1 online
summarizes their clinical and labora-
tory features. Fifteen SNPs on 11q13
and two SNPs of FLG with X90%
genotyping efficiency and in Hardy–-
Weinberg equilibrium were analyzed
(Supplementary Table S2 online). Two
FLG SNPs rs11584427 and rs1933064
were in complete linkage disequilib-
rium. Eczema diagnosis was not
associated with any single SNP. How-
ever, moderate-to-severe eczema was
associated with rs11584427 of FLG
(Supplementary Table S3 online).
Supplementary Tables S4 and S5 online
summarize results of linear regression
for logIgE and eos%, respectively.
LogIgE was associated with rs7124842
and rs3862807, and subjects homo-
zygous for major alleles of these SNPs
had higher total IgE levels. Eos% was
associated with rs2155219 (Supple-
mentary Table S6 online). GMDR ana-
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Figure 1. Interactions between filaggrin (FLG) and 11q13 locus for eczema phenotypes. Generalized
multifactor dimensionality reduction (GMDR) analyses for single-nucleotide polymorphism (SNP)–SNP
interactions showing the best two-locus models for (a) plasma total IgE concentration (logIgE) and (b)
circulating eosinophil percentage (eos%). Left bars in grids represent cases, whereas the right ones are
controls. Grids in dark are of the high-risk group and those in gray are of the low-risk group. The white
grid is unclassified. For post-hoc analyses, box plots for high- and low-risk groups as defined by GMDR
are provided for the interactions (c) between rs1933064 and rs2155219 for logIgE and (d) between
rs7927894 and rs2155219 for eos%. The median (25th–75th percentiles) values for the four groups are
shown on the right sides of the respective boxes. *Po0.001; **Po0.005.
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lyses revealed the best interaction
model for logIgE to be the two-way
combination of rs1933064 of FLG and
rs2155219 on 11q13 with the highest
cross-validation consistency (10 out
of the 10-fold cross-validation), which
was confirmed by the generalized
linear model (P¼1.1 107; Table 1).
For eos%, rs2155219/rs7927894 on
11q13 was the best two-locus model,
confirmed by linear regression (P¼1.5
104), whereas rs11584427/rs2155219/
rs7927894/rs10751256 was the best
four-locus model. Figure 1 illustrates the
assignment of subjects into high-risk or
low-risk groups. Total IgE levels were signi-
ficantly different among the four groups
(Po0.001), whereas eos% was higher in
high-risk than low-risk subjects (Po0.001)
among both patients and controls.
This study found that moderate-
to-severe childhood eczema was asso-
ciated with rs11584427 of FLG,
whereas rs1933064 of FLG and
rs2155219 on 11q13 interacted to
determine total IgE and rs2155219 and
rs7927894 on 11q13 interacted to
determine eos%. Such results support
both FLG and 11q13 to be candidate
loci for childhood eczema. Palmer
et al. (2006) showed that loss-of-func-
tion variants R510X and 2282del4 of
FLG were strong predisposing factors
for childhood eczema. FLG also con-
ferred susceptibility to other allergies
such as asthma, hay fever, and atopic
sensitization (Bisgaard et al., 2008;
Marenholz et al., 2009; Schuttelaar
et al., 2009). There was strong syner-
gistic interaction between FLG-null
alleles and early food sensitization in
the transition from eczema to asthma
(Marenholz et al., 2009). These findings
support the importance of FLG in
susceptibility for allergies. The first
GWAS reported noncoding rs7927894
on 11q13 to be associated with eczema
in German children (Esparza-Gordillo
et al., 2009). However, we could not
replicate such association possibly be-
cause of lower minor allele frequency
(MAF) in our Chinese population (0.23)
than that in Caucasians (0.36–0.41).
However, rs2155219 on 11q13 was
associated with eos% and interacted
with rs1933064 of FLG for total IgE
levels and with rs7927894 for eos%.
With regard to FLG, rs11584427 was
associated with moderate-to-severe
childhood eczema. Another SNP
(rs1933064) of FLG interacted with
rs2155219 on 11q13 to modulate
total IgE levels. These findings support
the importance of 11q13 and FLG
in the pathogenesis of childhood
eczema.
Our sample size of 1,230 cases and
1,113 controls had 80% power to detect
a risk allele with odds ratio 1.35 for
eczema at MAF 0.2 with 95% con-
fidence, but 70% power for SNP with
MAF 0.1 (EpiInfo, Center for Disease
Control and Prevention, Atlanta, GA).
Despite this, this study is adequately
powered to replicate the risk of 1.47
for rs7927894 on 11q13, as initially
reported (Esparza-Gordillo et al., 2009).
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